Cagrilintide 10mg – Specialized Analytical Standard for Incretin Research

Description

What is Cagrilintide & CAS 1415456-99-3?

High-precision research begins with verified chemical identity. Cagrilintide (CAS 1415456-99-3) is a long-acting, non-selective synthetic analogue of the human amylin hormone. It has been specifically bioengineered to exhibit high stability and prolonged biological activity, making it a cornerstone for modern weight management studies. By substituting key amino acids and incorporating a fatty acid side chain, Cagrilintide achieves a significantly extended half-life compared to endogenous amylin.

By utilizing rigorous vacuum-sealing and lyophilization protocols, 99Purity-Peptide offers a secure supply of this synthetic peptide for global laboratory use. This commitment to purity ensures that our Cagrilintide 10mg remains a reliable subject for investigating systemic metabolic regulation and the biochemical pathways of satiety.

Cagrilintide (CAS 1415456-99-3) Mechanism of Action and Research

The primary intrigue of Cagrilintide in laboratory environments is its role as an Amylin Receptor Agonist. In research models, it activates receptors in the hindbrain (area postrema) to signal fullness and slow gastric emptying, effectively regulating energy intake. Unlike GLP-1 agonists, Cagrilintide operates via the amylin pathway, providing researchers with a unique mechanism for studying appetite control that is independent of, yet potentially synergistic with, traditional incretin mimetics.

Current scientific investigations focus on Cagrilintide’s ability to reduce food intake and modulate glucose homeostasis without inducing the nausea often associated with other metabolic peptides. Its stable chemical architecture allows for precise dosing in longitudinal studies exploring the reversal of metabolic syndrome and long-term adipose tissue reduction.

Trending Research Topics & High-Authority Insights:

• Amylin Signaling and Satiety: Investigating non-GLP-1 pathways for appetite regulation.

• Cagrilintide and Energy Balance: Studies on weight set-point modulation in metabolic models.

• Cagrilintide: A long-acting amylin analogue for weight research – PubMed

Cagrilintide Specifications

Feature	Specification
Product Name	Cagrilintide
Available Strengths	2mg, 5mg, 10mg
Physical Appearance	White Lyophilized Powder
Purity	≥ 99% (HPLC/MS Verified)
Molecular Formula	$C_{180}H_{282}N_{50}O_{56}$
Molecular Weight	4094.5 g/mol
CAS Number	1415456-99-3
Verification	3rd-Party Lab Tested with COA
Storage Instructions	Store at -20°C (Long-term); 2-8°C after reconstitution

Cagrilintide Key Features & Benefits

• Pioneering Amylin Pathway Research: Targets the hindbrain to study appetite suppression mechanisms.

• Metabolic Rate Study Optimized: Ideal for research focusing on gastric emptying and energy expenditure.

• High-Purity Preparation: Synthesized at 99%+ purity to eliminate laboratory variables and ensure high-fidelity data.

• Sterile Lyophilized Powder: Vacuum-sealed for stability, ensuring structural integrity during global shipping.

• Independently Verified Identity: Each vial is confirmed via HPLC and Mass Spectrometry for absolute chemical precision.

Cagrilintide Research FAQ

How does Cagrilintide differ from Semaglutide in studies?

While Semaglutide targets the GLP-1 receptor, Cagrilintide targets the amylin receptor. Researchers often use Cagrilintide to study a different biological pathway for weight regulation, or to investigate how it performs when compared to traditional incretin-based models.

Why is Cagrilintide 10mg supplied as a freeze-dried powder?

Lyophilization is the industry standard for maintaining the integrity of sensitive peptide chains. By removing moisture and vacuum-sealing the vial, we prevent oxidation and hydrolysis, ensuring the Cagrilintide remains potent until it is reconstituted for your experiment.

What is the expected stability of reconstituted Cagrilintide?

Once the lyophilized powder is reconstituted with bacteriostatic water, it should be kept at 2-8°C. In a controlled laboratory setting, it is recommended to utilize the solution within 14-21 days to ensure peak research potency.

Can Cagrilintide be studied alongside other metabolic peptides?

Cagrilintide is frequently used in “co-administration” research protocols (such as with Semaglutide) to observe potential synergistic effects on weight loss and satiety signals.

Why Buy Cagrilintide online from 99Purity-Peptide?

• Elite Biotech Specialization: We understand that research outcomes depend on chemical purity. Our vials are synthesized to the highest analytical standards, providing a 99%+ pure medium for your laboratory.

• Discreet & Tracked Logistics: We prioritize the safe arrival of your research materials. All orders are sent in neutral, secure packaging with expedited delivery across the USA, UK, and Europe.

• Reliable Batch Consistency: Our manufacturing protocols ensure that the chemical profile of our Cagrilintide remains identical batch-after-batch, supporting reproducible data.

• Total Consumer Protection: From 3rd-party lab verification (COA) to secure payment options, we provide the professional reliability that serious metabolic researchers demand.

Payment Support & Logistics

• Secure Payment Options: We support multiple secure gateways, including Credit Cards, Cryptocurrency (USDT, USDC), PayPal, and Bank Transfers.

• Global Shipping: Fast, tracked delivery available to the United States, United Kingdom, and Europe.

• Processing Time: All orders are professionally handled and dispatched within 1-2 business days after payment confirmation.

Regulatory Disclaimer

99Purity-Peptide is a chemical supplier. We are not a compounding pharmacy or an outsourcing facility as defined under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act). All products are strictly for research, laboratory, or analytical use only and are NOT for human consumption.

References & Academic Links

• Enebo, B. A., et al. (2021). “Safety, tolerability, pharmacokinetics, and pharmacodynamics of cagrilintide.” The Lancet.

• Kruse, T., et al. (2021). “The design and development of cagrilintide, a long-acting amylin analogue.” Journal of Medicinal Chemistry.